|
In chronic wounds, unmanaged bioburden can progress to biofilm, which is challenging and often unresponsive to conventional treatment
|
|
|
| • |
Biofilm can adversely affect tissue repair and delay healing1,2
|
| • |
Biofilm can re-form within 24 hours following debridement3
|
| • |
Topical antimicrobials, such as silver, have demonstrated cytotoxic effects associated with delayed healing4,5
|
| • |
Systemic antibiotics can fail to reach adequate levels in localized tissue6
|
|
|
Now there is a novel technology to manage bioburden while supporting healing: PuraPly™ Antimicrobial (AM), the first purified collagen matrix with PHMB*7
Provides clinical benefits in 3 ways:
|
| 1. |
Purified Type I collagen matrix creates a durable, biocompatible scaffold8
|
| 2. |
Effective barrier against a wide range of microorganisms2,8
|
| 3. |
PHMB is known to disrupt and inhibit the formation of biofilm on the wound surface2
|
| *PHMB = polyhexamethylenebiguanide hydrochloride. |
|
|
|
|
|
Learn how PuraPly™ AM is changing the way some clinicians practice wound care
|
 |
|
"Not only does [PuraPly™] assist in healing because of purified collagen, it assists in the eradication of the bioburden and stopping the progression from a colonized to a critically colonized wound environment to support healing."
|
|
Jeffrey C. Karr, DPM
Karr Foot and Leg Center
Lakeland, FL
|
|
|
|
|
|
|
|
|
For more information, visit us at Booth 200 at the Symposium for Advanced Wound Care Conference, September 26-28 |
|
|
|
|
PuraPly™ Antimicrobial (AM): Manage a wide variety of wounds.
Shield against microbes.
|
References:
1. Mulder GD, Carvosi JP, Lee DK. Wounds. 2007;19(7):173-182. 2. Hubner NO, Kramer A. Skin Pharmacol Physiol. 2010;23(suppl):17-27. 3. Wolcott R, Cutting KF, Ruiz JC. Association for the Advancement of Wound Care. Publication No. UKCT-A0021. 2008:12-17. 4. Zou SB, Yoon WY, Han SK, Jeong SH, Cui ZJ, Kim WK. Int Wound J. 2013;10(3):306-312. 5. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Cochrane Database Syst Rev. 2010;(3):CD006478. 6.Leaper D, Snyder RJ. Association for the Advancement of Wound Care. Publication No. UKCT-A0021. 2008:5-9. 7. PuraPly Antimicrobial [package insert]. Canton, MA: Organogenesis Inc; 2015. 8. Data on file. Organogenesis Inc.
|
 |
©2015 Organogenesis Inc. OI-A1195 09-2015. All rights reserved. PuraPly Antimicrobial and PuraPly are trademarks of Organogenesis Inc. Please see complete prescribing information at www.organogenesis.com.
|
|
This email was sent to: %%Email Address%%
This email was sent by: %%Member_Busname%%
%%Member_Addr%% %%Member_City%%, %%Member_State%% %%Member_PostalCode%%
%%Member_Country%% |
We respect your right to privacy - view our policy |
|
|
|
